Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Annals of Hematology
|
June 10, 1998
A case of bone marrow mastocytosis associated with multiple myeloma
W Hagen, J Schwarzmeier, S Walchshofer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 23, 1999
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis
C Sillaber, M Baghestanian, D Bevec, et al.
European Journal of Clinical Investigation
|
August 31, 2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy
K J Aichberger, S Herndlhofer, H Agis, et al.
European Journal of Clinical Investigation
|
January 5, 2008
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia
C Sillaber, M Mayerhofer, A Böhm, et al.
Wiener Klinische Wochenschrift
|
April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis
F Wimazal, S Walchshofer, M Baghestanian, et al.
Journal of Cancer Research and Clinical Oncology
|
February 28, 2016
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
W Rabitsch, M Bojic, P Wohlfarth, et al.
Leukemia
|
May 1, 1997
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia
D Schmid, G Heinze, B Linnerth, et al.
British Journal of Haematology
|
December 19, 1998
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val
W R Sperr, S Walchshofer, H P Horny, et al.
Current Cancer Drug Targets
|
June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy
K V Gleixner, M Mayerhofer, A Vales, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cells
C Sillaber, M Baghestanian, R Hofbauer, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Annals of Hematology
|
June 10, 1998
A case of bone marrow mastocytosis associated with multiple myeloma
W Hagen, J Schwarzmeier, S Walchshofer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 23, 1999
The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis
C Sillaber, M Baghestanian, D Bevec, et al.
European Journal of Clinical Investigation
|
August 31, 2007
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy
K J Aichberger, S Herndlhofer, H Agis, et al.
European Journal of Clinical Investigation
|
January 5, 2008
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia
C Sillaber, M Mayerhofer, A Böhm, et al.
Wiener Klinische Wochenschrift
|
April 29, 1998
Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis
F Wimazal, S Walchshofer, M Baghestanian, et al.
Journal of Cancer Research and Clinical Oncology
|
February 28, 2016
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
W Rabitsch, M Bojic, P Wohlfarth, et al.
Leukemia
|
May 1, 1997
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia
D Schmid, G Heinze, B Linnerth, et al.
British Journal of Haematology
|
December 19, 1998
Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val
W R Sperr, S Walchshofer, H P Horny, et al.
Current Cancer Drug Targets
|
June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy
K V Gleixner, M Mayerhofer, A Vales, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cells
C Sillaber, M Baghestanian, R Hofbauer, et al.
Page
of 5